N. Kumarasamy

564 total citations
20 papers, 381 citations indexed

About

N. Kumarasamy is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, N. Kumarasamy has authored 20 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Virology. Recurrent topics in N. Kumarasamy's work include HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (5 papers). N. Kumarasamy is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (5 papers). N. Kumarasamy collaborates with scholars based in India, United States and Sweden. N. Kumarasamy's co-authors include Amala George, Jyotirmay Biswas, S Solomon, Selvamuthu Poongulali, Suniti Solomon, Purnima Madhivanan, Kenneth H. Mayer, John S. Lambert, Steven Shoptaw and Rochelle P. Walensky and has published in prestigious journals such as JAMA, American Journal of Ophthalmology and PLoS neglected tropical diseases.

In The Last Decade

N. Kumarasamy

19 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Kumarasamy India 10 196 189 116 78 50 20 381
Fatma Sargın Türkiye 11 115 0.6× 99 0.5× 45 0.4× 20 0.3× 15 0.3× 25 235
P. de Truchis France 10 351 1.8× 201 1.1× 251 2.2× 27 0.3× 28 0.6× 20 589
C. van der Horst United States 9 121 0.6× 168 0.9× 25 0.2× 14 0.2× 33 0.7× 11 357
Pei‐Hung Chuang Taiwan 12 122 0.6× 141 0.7× 31 0.3× 6 0.1× 38 0.8× 25 320
Sheila M. Gore United Kingdom 5 88 0.4× 143 0.8× 33 0.3× 70 0.9× 79 1.6× 8 340
Thinh N. Le Canada 12 248 1.3× 177 0.9× 172 1.5× 4 0.1× 24 0.5× 15 393
Romain Palich France 13 327 1.7× 141 0.7× 127 1.1× 4 0.1× 25 0.5× 70 493
Jamila Aboulhab Singapore 7 198 1.0× 46 0.2× 61 0.5× 11 0.1× 54 1.1× 9 299
Rodrigo de Carvalho Santana Brazil 12 99 0.5× 139 0.7× 12 0.1× 26 0.3× 67 1.3× 39 440
C Leport France 7 219 1.1× 138 0.7× 160 1.4× 6 0.1× 22 0.4× 31 428

Countries citing papers authored by N. Kumarasamy

Since Specialization
Citations

This map shows the geographic impact of N. Kumarasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Kumarasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Kumarasamy more than expected).

Fields of papers citing papers by N. Kumarasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Kumarasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Kumarasamy. The network helps show where N. Kumarasamy may publish in the future.

Co-authorship network of co-authors of N. Kumarasamy

This figure shows the co-authorship network connecting the top 25 collaborators of N. Kumarasamy. A scholar is included among the top collaborators of N. Kumarasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Kumarasamy. N. Kumarasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumarasamy, N., Seth C. Kalichman, David R. Holtgräve, et al.. (2023). HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society–USA Panel. UNC Libraries.
2.
Kumarasamy, N.. (2016). The impact of antiretroviral therapy in resource‐limited settings and current HIV therapeutics. Oral Diseases. 22(S1). 42–45. 3 indexed citations
3.
Talaat, Kawsar R., Subash Babu, Pradeep A. Menon, et al.. (2015). Treatment of W. bancrofti (Wb) in HIV/Wb Coinfections in South India. PLoS neglected tropical diseases. 9(3). e0003622–e0003622. 6 indexed citations
4.
Shet, Anita, et al.. (2015). Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study. BMC Pediatrics. 15(1). 164–164. 22 indexed citations
5.
Marrazzo, Jeanne, Carlos del Rı́o, David R. Holtgräve, et al.. (2014). HIV Prevention in Clinical Care Settings. JAMA. 312(4). 390–390. 88 indexed citations
6.
Shyamsunder, Pavithra, Kannan Ranganathan, UmadeviK Rao, et al.. (2013). Impact of highly active antiretroviral therapy on salivary flow in patients with human-immuno deficiency virus disease in Southern India. Journal of Oral and Maxillofacial Pathology. 17(1). 17–17. 6 indexed citations
7.
Muttan, S., et al.. (2011). Virus infection on brain white matter: statistical analysis of DT MRI scans. International Journal of Bioinformatics Research and Applications. 7(3). 273–273. 3 indexed citations
8.
Kumarasamy, N., Kartik K. Venkatesh, Selvamuthu Poongulali, et al.. (2011). Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients. Journal of the International Association of Physicians in AIDS Care. 10(2). 71–75. 4 indexed citations
9.
Shankar, Esaki M., et al.. (2010). Pulmonary microbiology of HIV positive subjects with community-acquired pneumonia (CAP) with special emphasis on Mycoplasma pneumoniae. International Journal of Infectious Diseases. 14. e401–e401. 2 indexed citations
10.
Kumarasamy, N., et al.. (2008). Safety, Tolerability and Effectiveness of Generic HAART in HIV-Infected Children in South India. Journal of Tropical Pediatrics. 55(3). 155–159. 31 indexed citations
11.
Sundaram, M., K Murugavel, Esaki M. Shankar, et al.. (2007). Ethnic variation in certain hematological and biochemical reference intervals in a south Indian healthy adult population. European Journal of Internal Medicine. 19(1). 46–50. 25 indexed citations
12.
Kumarasamy, N., et al.. (2006). Glaucoma: Current and Developing Concepts for Inflammation, Pathogenesis and Treatment. European Journal of Inflammation. 4(3). 129–137. 18 indexed citations
13.
Balakrishnan, Pachamuthu, Sunil S. Solomon, K Murugavel, et al.. (2005). HIV-1 western blot assay: What determines an indeterminate status?. PubMed. 59(10). 443–50. 12 indexed citations
15.
Balakrishnan, Pachamuthu, et al.. (2005). HIV-1 western blot assay: What determines an indeterminate status?. Indian Journal of Medical Sciences. 59(10). 443–443. 11 indexed citations
16.
Madhivanan, Purnima, et al.. (2003). Clinical manifestations of HIV infected children. The Indian Journal of Pediatrics. 70(8). 615–620. 49 indexed citations
17.
Kumarasamy, N., et al.. (2001). Multiple cranial nerve palsy in an HIV-positive patient.. PubMed. 49(2). 118–20. 4 indexed citations
18.
Biswas, Jyotirmay, et al.. (2000). Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. American Journal of Ophthalmology. 129(1). 9–15. 76 indexed citations
19.
Biswas, Jyotirmay, et al.. (2000). Ocular and systemic lesions in children with HIV. The Indian Journal of Pediatrics. 67(10). 721–724. 10 indexed citations
20.
Madhavan, HN, et al.. (2000). Acute panuveitis with haemorrhagic hypopyon as a presenting feature of acquired immunodeficiency syndrome (AIDS).. PubMed. 48(4). 311–2. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026